Virus-mimetic nanoparticles for diabetic nephropathy
Virus-mimetic nanoparticles for diabetic nephropathy
- Specific drug delivery via nanoparticles
- Virus like targeting in a two-stage process
- Dose reduction compared to free drug
-
Virus-mimetic nanoparticles for diabetic nephropathy
-
Active emulgels for controlled zero-order drug release
Active emulgels for controlled zero-order drug release
- Platform for zero-order (linear) drug-release
- Constant, tunable release of hydrophobic drugs
- 3 components, economical and straightforward
-
Hydrogels: Injectable Depot-Systems
Hydrogels: Injectable Depot-Systems
- Gelatinize by a dual mechanism based on Diels-Alder reaction and physical crosslinking
- Stability and stiffness can be adjusted to therapeutic need
- Hydrogels are stable, in situ forming, non-toxic and particularly suitable for controlled drug release
3 von 113 Tech Offers
